Blog

Now that novel food applications in Europe are delayed, what does enforcement look like?

Written by CBD-Intel || 10th July 2020 || Blog |

Europe
Companies
Food
Health
Policy and Politics
Regulation and Legislation
Blog
Enforcement activity against food, drink and dietary supplement products placed on the market containing CBD continues despite the inability of companies to proceed with novel food applications due to the EC's questions over whether CBD constitutes a narcotic under...

How is the novel food status of CBD progressing in Europe?

Written by CBD-Intel || 3rd July 2020 || Blog |

Europe
Companies
Food
Health
Policy and Politics
Regulation and Legislation
Blog
Several major developments have all happened at the same time for novel foods. Perhaps most importantly, one of the European Commission's departments - the  Directorate-General for Health and Food Safety - has said it is holding sending any further...

What inference can be drawn from the Italian enforcement action against EasyJoint?

Written by CBD-Intel || 11th June 2020 || Blog |

Europe
Italy
Regulation and Legislation
Blog
The suspension of EasyJoint’s commercial activities and website pending a trial in the Italian province of Parma demonstrates that enforcement authorities intend to continue to police CBD retailers. In particular, it seems the Parma prosecutor’s office took exception to the marketing...

What impact does cannabis have on bankruptcy proceedings?

Written by JuditBach || 29th May 2020 || Blog |

North America
United States
Regulation and Legislation
Blog
Businesses in the US should be aware of ongoing proceedings in bankruptcy courts related to companies that have been involved in cannabis. Bankruptcy filings and proceedings are unavailable to these companies as it remains an illegal substance at...

What implications can the industry draw from the recent Court of Justice of the European Union (CJEU) opinion in the ongoing French Kanavape case?

Written by JuditBach || 15th May 2020 || Blog |

France
Regulation and Legislation
Blog
France cannot stop the import of full spectrum CBD oils extracted from any part of the plant, including flowers, from other EU member states UNLESS it has scientifically established that CBD has psychotropic or toxic effects, and considered whether there were no alternative less-burdensome regulation to an outright...

Did COVID-19 have much of an impact on 4/20 sales?

Written by JuditBach || 8th May 2020 || Blog |

World
COVID-19
Blog
The answer is not quite clear. A lot of companies reported no drop or even increases in sales compared to the previous year. There could be several reasons for this. Firstly, all cannabinoid-related products are still part of...

Will COVID lead to delays in regulatory procedures?

Written by JuditBach || 1st May 2020 || Blog |

Europe
North America
United Kingdom
United States
World
COVID-19
Blog
The ongoing pandemic lockdown looks to be ending in some areas with easing of measures in numerous jurisdictions. But the months lost – and continued social distancing measures which will not be entirely lifted in the near future...

What aid is available for US CBD firms affected by coronavirus?

Written by JuditBach || 24th April 2020 || Blog |

North America
United States
COVID-19
Blog
CBD businesses in the US that have seen business impacted by the coronavirus pandemic and associated social measures could be eligible for a variety of state aid programmes. Extra funding for the programmes was just approved by both the...

How the COVID-19 crisis may impact the CBD market?

Written by JuditBach || 17th April 2020 || Blog |

Africa
Asia
Australasia
Europe
North America
South America
World
COVID-19
Blog
Closures of non-essential retail will be far and away the largest factor impacting on CBD markets across the globe. It is estimated that up to 90% of offline sales in markets such as the UK happen through channels...